BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20250731T042131EDT-34587WjXES@132.216.98.100 DTSTAMP:20250731T082131Z DESCRIPTION:Applied Mass Spectrometry [food/nutrition/environment and agric ulture] @ ºÚÁϲ»´òìÈ - Macdonald Campus\n\nGuest speaker: Prof Pierre Chaurand \, Department of Chemistry\, Université de Montréal\n\nImaging mass spectr ometry (IMS) has become the leading technique for the analysis of biomolec ules directly from thin tissue sections while retaining the biomolecules’ anatomical distributions. In recent years\, MALDI IMS as greatly improved in spatial resolution due to the advancement in both sample preparations a nd instruments to the point of reaching cellular level capabilities. In th is workshop\, after giving an overview of IMS technology and of its potent ial\, new developments in IMS from our laboratory to increase specificity and sensitivity will be presented. More specifically\, matrix-free metal a ssisted LDI IMS methods have been developed for the specific analysis of n eutral lipid compounds. For these\, nanometer thin metal layers are direct ly sputter deposited on tissue sections. From the investigation of various tissue specimens\, using silver-assisted LDI IMS we have thus far mapped and identified several compounds including\, cholesterol\, arachidonic aci d and docosahexaenoic acid. While both fatty acids and cholesterol show gr eat affinity for silver\, other molecules such as triglycerides have stron g affinities for sodium cations. For this purpose\, the coupling of sodium salts and sputtered layers of gold has been developed to enhance both des orption and ionization of triglycerides yielding a 30-fold increase in sig nal compared to standard MALDI MS approaches. Although gold-assisted LDI I MS targets triglycerides\, we have also detected and imaged several other compounds including cholesterol esters\, which are hard to detect by MALDI MS. The clinical potentials of these novel IMS strategies for the detecti on and characterization of molecular changes in disease has been exemplifi ed through studies of Alzheimer’s and non-alcoholic fatty liver diseases. \n\nABOUT THE SPEAKER\n\nPierre Chaurand received his Ph.D. in physical ch emistry from the Université Paris Sud\, (Orsay\, France) in 1994. After a postdoctoral period at the Heinrich-Heine Universität\, (Düsseldorf\, Germ any)\, he integrated in 1998 the laboratory of Prof. Richard Caprioli as R esearch Faculty at Vanderbilt University School of Medicine (Nashville TN\ , USA). Since 2009\, he is Professor in the Department of Chemistry at the Université de Montréal (Montreal\, Canada). His primary background is in biochemistry with significant analytical and organic chemistry components. His current expertise’s are in fundamental and analytical mass spectromet ry. With over 20 years of experience in the field\, he is one of the pione ers of the imaging mass spectrometry (IMS) technology. His current researc h interests are focused on the development of new strategies and methods t o improve the specificity and sensitivity of tissue based IMS with applica tions in fundamental and clinical biology.\n\nEveryone is welcome to atten d.\n DTSTART:20190221T163000Z DTEND:20190221T173000Z LOCATION:R4-045\, Raymond Building\, CA\, QC\, St Anne de Bellevue\, H9X 3V 9\, 21111 Lakeshore Road SUMMARY:Novel sample preparation approaches for LDI imaging MS to answer ke y biological questions URL:/macdonald/channels/event/novel-sample-preparation -approaches-ldi-imaging-ms-answer-key-biological-questions-294557 END:VEVENT END:VCALENDAR